Hinge Health is trading 4.2% up at $80.91 as investors position ahead of its Q2 2026 earnings report and a broader risk-on market rally.
- The company is scheduled to report results on August 4, 2026, with analysts expecting approximately $201 million in revenue and $0.55 EPS.
- Sentiment is further bolstered by strong manufacturing data and easing geopolitical tensions, which have lifted growth and tech-related names across major U.S. indices.